Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cybin Inc. Common Shares
(NY:
CYBN
)
8.280
UNCHANGED
Last Price
Updated: 8:00 PM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cybin Inc. Common Shares
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
21
22
Next >
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
↗
June 27, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 3.12% at $0.82
Via
Benzinga
Rebalanced Psychedelic Compounds-Based Drug Stocks Index Down 52.7% YTD
↗
June 27, 2022
The Psychedelic Compounds-Based Drug Stocks Index is down 52.7% YTD and down 75.9% from its highest point in 2021.
Via
Talk Markets
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
↗
June 24, 2022
GAINERS: Allied (OTC:ALID) shares closed up 29.44% at $0.56
Via
Benzinga
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
↗
June 23, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 6.63% at $0.71
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 22, 2022
↗
June 22, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 4.17% at $3.50
Via
Benzinga
Cybin Closes Fiscal Year 2022, Reports Financial Results And Major Achievements
↗
June 22, 2022
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), a biopharma company focused on progressing “psychedelics to therapeutics” through proprietary drug discovery platforms announced its financial and business...
Via
Benzinga
10 Psychedelics CEOs To Pay Attention To In 2022
↗
June 22, 2022
By Javier Hasse and Aaron Bry. 2020 and 2021 were defining years for the burgeoning psychedelics industry. In 2021 alone, more than $730 million were invested into various psychedelic companies, both...
Via
Benzinga
Revive Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today
↗
June 21, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 7.43% at $0.31
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 17, 2022
↗
June 17, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 5.69% at $0.67
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 16, 2022
↗
June 16, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.08% at $10.05 LOSERS:
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 15, 2022
↗
June 15, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 9.11% at $0.62
Via
Benzinga
Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill
↗
June 15, 2022
Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider.
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 14, 2022
↗
June 14, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 9.90% at $9.44
Via
Benzinga
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today
↗
June 13, 2022
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 1.06% at $0.81 LOSERS:
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
June 13, 2022
Good morning, traders! We're starting off the week with a dive into the biggest pre-market stock movers for Monday morning!
Via
InvestorPlace
Cybin Moves Forward With Phase 1/2a Clinical Trial For Treatment Of Major Depressive Disorder
↗
June 10, 2022
Cybin Inc.
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 10, 2022
↗
June 10, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 6.16% at $0.67
Via
Benzinga
Elon Musk Says Psychedelics Should Be Seriously Considered For Therapeutic Uses, Leading Chorus Of Celeb Support
↗
June 10, 2022
Elon Musk, the Tesla multi-billionaire investor and owner of the largest portion of Twitter (NYSE: TWTR) shares has been discus
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
June 10, 2022
Good morning, investors! With another day starting comes another breakdown of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
↗
June 09, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 12.55% at $0.13
Via
Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
↗
June 08, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 7.70% at $0.78
Via
Benzinga
Psyched: Christie's Launches NFT Collection Supporting Psychedelic Science, Origin's Listing On CSE Gives Retail Investors Access To Private Companies
↗
June 08, 2022
The world of psychedelics is getting a crossover with another category in the millennial catalog of trendy investments: NFTs.
Via
Benzinga
Largest Phase-1 DMT Study In The Netherlands, A Collaboration Between Entheon & Cybin
↗
June 07, 2022
Cybin Inc. (NEO:CYBN) (NYSE American: CYBE) announced that, through its wholly-owned subsidiary Cybin IRL Limited, It has entered into an agreement to acquire a Phase 1 N,N-dimethyltryptamine (“DMT”)...
Via
Benzinga
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
↗
June 07, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 9.47% at $0.72
Via
Benzinga
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
↗
June 06, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 3.55% at $0.36
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 3, 2022
↗
June 03, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 5.88% at $0.35
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
↗
June 02, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 9.50% at $0.75
Via
Benzinga
ATAI Life Sciences, Intelgenx Technologies Among Top Psychedelic Movers Of Today
↗
June 01, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 7.05% at $0.91
Via
Benzinga
Psychedelic Stock Gainers And Losers From May 31, 2022
↗
May 31, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 8.54% at $0.36
Via
Benzinga
Major Depressive Disorder Could Soon Have Treatment Option Via Cybin's Psilocybin Analog
↗
May 31, 2022
Cybin Inc. (CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics," has submitted an Investigational New Drug (or “IND”) application to the FDA.
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
21
22
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.